I did mention they could take on debt like other hospitals? Right now they are net debt free and even on an absolute basis, the leverage is low. But since debt also exists, hence ROCE and not ROE. As a metric, ROE is more relevant for banks since they’re anyways highly levered & medium for raising capital becomes equity more often than debt.
Past isn’t always a good predictor for future in investing. Not sure how this is relevant on a going forward basis since much has changed operationally (higher ARPOB, case mix, etc.)
Sure, and borrowing debt is fine… they’re pretty much on a net debt free status right now… 5crs of gross debt against 100crs+ of cash. Also the Op leverage is already kicking in… they have pretty high EBITDA margins compared to some others and they only seem to be stabilising at ~30% on a steady state basis (excl. growing hospitals - Jhansi & Faridabad)
Nuvama come up with research report.
Going Forward:
Capacity expansion by adding beds, occupancy increase on Jhansi and Faridabad hospital which are currently at approx. 25% AND 15%.
Margin expansion due to increase in ARPOB, Which is at 59% discount to peers in Delhi-NCR region, it will be supported by specialty clinics and treatment.
Narrowing down of valuation gap compared to peers.
Thanks for sharing this! I appreciate your effort.
I have a quick question - why do people post Excel links instead of direct Google Sheet links? With a Google Sheet, we could bookmark it and easily go back. For Excel files, we have to download them each time. Just curious about the reasoning behind this choice.
Company may decide to change the rating agency. In this case existing agency will mention in their report that the issuer company is not co-operating. Over the period of time another agency might come up with new ratings. This is normal and should not be taken seriously.